A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

Open Access
Publisher Website
Google Scholar
Abstract
Chronic granulomatous disease is an uncommon inherited disorder of phagocytes in which defective production of the reactive intermediates of oxygen predisposes patients to recurrent and severe pyogenic infections. Evidence from in vitro and in vivo studies indicates that interferon gamma can partially correct the metabolic defect in phagocytes. We assessed the efficacy of interferon gamma in decreasing the frequency of serious infections in patients with this disease.

This publication has 36 references indexed in Scilit: